Abstract
Abstract
Current medical device regulation is insufficient for addressing the unique features and evolving nature of AI technology, leaving gaps that regulators across the world are working to close. In this
News and Perspectives
article, JMIR Correspondent Tejas S Athni reports on a recently released report outlining 44 recommendations that, if implemented, could provide a more comprehensive, life cycle–based regulatory framework for health care AI in the United Kingdom.